PT643963E - BIODEGRADAVEL DEVICE FOR ADMINISTRATION OF ACTIVE SUBSTANCES - Google Patents
BIODEGRADAVEL DEVICE FOR ADMINISTRATION OF ACTIVE SUBSTANCESInfo
- Publication number
- PT643963E PT643963E PT94302638T PT94302638T PT643963E PT 643963 E PT643963 E PT 643963E PT 94302638 T PT94302638 T PT 94302638T PT 94302638 T PT94302638 T PT 94302638T PT 643963 E PT643963 E PT 643963E
- Authority
- PT
- Portugal
- Prior art keywords
- hours
- biodegradavel
- administration
- active substances
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S261/00—Gas and liquid contact apparatus
- Y10S261/26—Foam
Abstract
The invention relates to a muco-adherent, soluble device for administering active ingredients, a method of using said device, and an improved method of manufacturing said device using a continuous, enclosed mixing device capable of operating under pressure. The devices of the invention, which comprise a lyophilized foam and an active ingredient, have a dissolution time of at least about 8 hours, and preferably at least about 24 hours, and can provide for the sustained and/or controlled release of an active ingredient for up to about 24 hours.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/104,785 US5458884A (en) | 1992-09-10 | 1993-08-16 | Bioerodible device for administering active ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
PT643963E true PT643963E (en) | 2002-05-31 |
Family
ID=22302367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94302638T PT643963E (en) | 1993-08-16 | 1994-04-13 | BIODEGRADAVEL DEVICE FOR ADMINISTRATION OF ACTIVE SUBSTANCES |
Country Status (8)
Country | Link |
---|---|
US (1) | US5458884A (en) |
EP (1) | EP0643963B1 (en) |
KR (1) | KR100277483B1 (en) |
AT (1) | ATE208612T1 (en) |
DE (1) | DE69429048T2 (en) |
DK (1) | DK0643963T3 (en) |
ES (1) | ES2171165T3 (en) |
PT (1) | PT643963E (en) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2105887C (en) * | 1992-09-10 | 2004-03-16 | Peter Britton | Bioerodible device for administering active ingredients |
US6479457B2 (en) | 1995-06-06 | 2002-11-12 | Kinerton Limited | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
US5656283A (en) * | 1995-06-08 | 1997-08-12 | Ortho Pharmaceutical Corporation | In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product |
US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
US6624200B2 (en) | 1998-08-25 | 2003-09-23 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US8765177B2 (en) * | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US6248358B1 (en) | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
EP1123696B1 (en) * | 1998-09-25 | 2006-05-24 | Kao Corporation | Compositions for oral cavity |
US6284262B1 (en) * | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
US6090401A (en) * | 1999-03-31 | 2000-07-18 | Mcneil-Ppc, Inc. | Stable foam composition |
SE514342C2 (en) * | 1999-05-31 | 2001-02-12 | Nobel Biocare Ab | Method, apparatus and use in implants to ensure delivery of bioactive substance to the surrounding bone and / or tissue of the implant |
US20020076440A1 (en) * | 1999-06-25 | 2002-06-20 | Thomas Leon | Veterinary delivery systems and methods of delivering effective agents to animals |
GB2355008A (en) * | 1999-10-05 | 2001-04-11 | Procter & Gamble | Foam matrix coating material |
US6943200B1 (en) | 1999-10-05 | 2005-09-13 | Procter & Gamble Company | Water unstable foam compositions |
AU7752400A (en) * | 1999-10-05 | 2001-05-10 | Procter & Gamble Company, The | Water unstable foam |
WO2001025323A1 (en) * | 1999-10-05 | 2001-04-12 | The Procter & Gamble Company | Elastic articles and uses thereof |
GB2355014A (en) * | 1999-10-05 | 2001-04-11 | Procter & Gamble | Foams and compositions containing these foams |
US6555125B2 (en) | 1999-11-30 | 2003-04-29 | Phillip Campbell | Lesion and ulcer medication |
US6352711B1 (en) * | 1999-11-30 | 2002-03-05 | Phillip Campbell | Lesion and ulcer medication |
JP2004504887A (en) * | 2000-08-02 | 2004-02-19 | アエスクラップ アーゲー ウント コー カーゲー | Medical technology products, their production methods and their surgical uses |
US7198801B2 (en) | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
GB2366797A (en) * | 2000-09-13 | 2002-03-20 | Procter & Gamble | Process for making foam component by pressurising/depressurising |
US6756051B1 (en) * | 2000-11-15 | 2004-06-29 | Li-Lan H. Chen | Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
US7897832B2 (en) * | 2001-06-14 | 2011-03-01 | Hemcon Medical Technologies, Inc. | Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan |
AU2002312493B2 (en) | 2001-06-14 | 2007-08-09 | Gregory, Kenton W | Wound dressing and method for controlling severe, life-threatening bleeding |
US7371403B2 (en) | 2002-06-14 | 2008-05-13 | Providence Health System-Oregon | Wound dressing and method for controlling severe, life-threatening bleeding |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US20050137512A1 (en) | 2003-12-23 | 2005-06-23 | Campbell Todd D. | Wound dressing and method for controlling severe, life-threatening bleeding |
US8269058B2 (en) | 2002-06-14 | 2012-09-18 | Hemcon Medical Technologies, Inc. | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
BR0315194A (en) * | 2002-10-31 | 2005-08-23 | Umd Inc | Therapeutic Compositions for Drug Release to and Through Epithelial Coverage |
US20040151756A1 (en) * | 2003-02-04 | 2004-08-05 | Richards Anthony P. | Edible low density high surface area drug vehicle, method of manufacturing low density high surface area drug vehicle |
PT1670433E (en) | 2003-10-10 | 2012-02-08 | Ferring Bv | Transdermal pharmaceutical formulation for minimizing skin residues |
US9204957B2 (en) | 2005-03-17 | 2015-12-08 | Hemcon Medical Technologies, Inc. | Systems and methods for hemorrhage control and or tissue repair |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
CA2646667C (en) | 2006-04-21 | 2014-03-11 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
EP2026850B1 (en) | 2006-05-23 | 2014-07-09 | Providence Health System-Oregon d/b/a Providence St. Vincent Medical Center | Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ |
WO2009134447A1 (en) | 2008-05-02 | 2009-11-05 | Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center | Wound dressing devices and methods |
WO2010042540A1 (en) | 2008-10-06 | 2010-04-15 | Providence Health System - Oregon | Foam medical devices and methods |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
BR112018072539A2 (en) | 2016-05-05 | 2019-03-26 | Aquestive Therapeutics, Inc. | increased administration epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
DE102017112527B4 (en) * | 2017-06-07 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Fast disintegrating foam wafers with a high basis weight |
EP4122980A4 (en) * | 2020-03-17 | 2024-03-27 | Japan Tobacco Inc | Porous body production method and porous body |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
FR2634376B1 (en) * | 1988-07-21 | 1992-04-17 | Farmalyoc | NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION |
US4948580A (en) * | 1988-12-08 | 1990-08-14 | E. R. Squibb & Sons, Inc. | Muco-bioadhesive composition |
US5039540A (en) * | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
DE4119140C2 (en) * | 1991-06-11 | 1994-05-11 | Merz & Co Gmbh & Co | Porous spongeoid moldings soluble in body fluids and secretions, their preparation and use |
US5354558A (en) * | 1992-09-10 | 1994-10-11 | Mcneil-Pcc, Inc. | Bioerodible contraceptive suppository |
-
1993
- 1993-08-16 US US08/104,785 patent/US5458884A/en not_active Expired - Lifetime
- 1993-09-10 KR KR1019930018263A patent/KR100277483B1/en not_active IP Right Cessation
-
1994
- 1994-04-13 EP EP94302638A patent/EP0643963B1/en not_active Expired - Lifetime
- 1994-04-13 AT AT94302638T patent/ATE208612T1/en not_active IP Right Cessation
- 1994-04-13 ES ES94302638T patent/ES2171165T3/en not_active Expired - Lifetime
- 1994-04-13 DK DK94302638T patent/DK0643963T3/en active
- 1994-04-13 PT PT94302638T patent/PT643963E/en unknown
- 1994-04-13 DE DE69429048T patent/DE69429048T2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69429048D1 (en) | 2001-12-20 |
EP0643963A3 (en) | 1996-09-11 |
ES2171165T3 (en) | 2002-09-01 |
EP0643963B1 (en) | 2001-11-14 |
ATE208612T1 (en) | 2001-11-15 |
KR940006574A (en) | 1994-04-25 |
DE69429048T2 (en) | 2002-07-11 |
DK0643963T3 (en) | 2002-03-11 |
KR100277483B1 (en) | 2001-09-17 |
US5458884A (en) | 1995-10-17 |
EP0643963A2 (en) | 1995-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT643963E (en) | BIODEGRADAVEL DEVICE FOR ADMINISTRATION OF ACTIVE SUBSTANCES | |
CA2105887A1 (en) | Bioerodible device for administering active ingredients | |
BR9607752A (en) | Pharmaceutical formulation of controlled release microcapsules, process for their preparation, and process of using microcapsules | |
ITBO940379A0 (en) | APPARATUS AND METHOD FOR PREPARING SOLID PHARMACEUTICAL FORMS WITH CONTROLLED RELEASE OF THE ACTIVE INGREDIENT. | |
ATE109000T1 (en) | DRUG RELEASE SYSTEM AND ITS METHOD OF MANUFACTURE. | |
DK0841903T3 (en) | Oral pharmaceutical preparations containing antimicrobially active active substances and sustained release pantoprazole | |
GEP20022707B (en) | Biodegrading Macromers for the Controlled Release of Biologically Active Substances | |
CA2004598A1 (en) | Medicinal aerosol formulations | |
EP0189861A3 (en) | Percutaneous absorption accelerator for ionic water-soluble medicine | |
HU900108D0 (en) | Composition of controlled active ingredient delivery, operating by hydrogel | |
AU3990797A (en) | Sustained release formulation | |
CA2260750A1 (en) | Methods for providing safe local anesthesia | |
AU6675198A (en) | Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use | |
DK0589893T3 (en) | Use of a bacteriocin as an antimicrobial agent for the manufacture of a medicament for the treatment of gastric disorders associated with helicobacter pylori | |
WO2001068038A3 (en) | System for the controlled delivery of an active material to a dental site | |
ES2098920T3 (en) | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF NICOTINE DEPENDENCE. | |
HUT75029A (en) | Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient | |
ES2186207T3 (en) | METHOD FOR PREPARATION OF PHARMACEUTICAL FORMULATIONS. | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
HRP20000781B1 (en) | Effervescent preparations | |
HU9700842D0 (en) | Pharmaceutical compositions based on stabilized lipophyl matrix giving controlled release for the active components | |
DK0626173T3 (en) | Aerosol preparation containing fusafungin | |
BRPI9607752B8 (en) | controlled release microcapsule pharmaceutical formulation. | |
MX9305530A (en) | WOUND DRESSING, LYOPHILIZED FOAM. | |
ZA9711270B (en) | Precursory forms and new analogues of camptothecin, the processes for their preparation, their medical application and the pharmaceutical substances that contain them. |